Table 2.
Clinical characteristics and outcome of patients treated with antibiotic lock therapy (ALT) for catheter-associated bacteremia.
| S. No. | Age/sex | Organism isolated | Type of catheter | ANC (mm3) | Name of ALT | Dose of ALT (mg) | Dwell time (hours) | No. of ALT doses | Days of ALT | Persistent bacteremia | Catheter salvage | Relapse |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 5 yr/M | Pseudomonas aeruginosa | Port-a-catheter | 1915 | Ciprofloxacin | 0.6 | 48 | 5 | 10 | No | Yes | No |
| 2 | 5 yr/F | Staphylococcus aureus | Port-a-catheter | 2869 | Cloxacillin | 300.0 | 48 | 4 | 8 | No | Yes | Yes |
| 3 | 2 yr/F | Staphylococcus non-aureus sp. | Port-a-catheter | 3542 | Vancomycin | 7.5 | 24 | 1 | 1 | No | Yes | No |
| 4 | 7 yr/M | Staphylococcus non-aureus sp. | PICC line | 5464 | Vancomycin | 7.5 | 48 | 1 | 1 | No | Yes | No |
| 5 | 2 yr/F | Staphylococcus saprophyticus | Port-a-catheter | 1890 | Vancomycin | 7.5 | 48 | 4 | 8 | No | Yes | Yes |
| 6 | 1 yr/M | Enterococcus species | Port-a-catheter | 7724 | Vancomycin | 7.5 | 48 | 2 | 4 | No | Yes | No |
| 7 | 4 yr/F | Brevibacterium | Port-a-catheter | 539 | Vancomycin | 7.5 | 48 | 3 | 7 | No | Yes | No |
| 8 | 12 yr/M | Staphylococcus non-aureus sp. | PICC line | 3060 | Vancomycin | 5.0 | 24 | 3 | 3 | Yes | No | No |
| 9 | 15 yr/M | Bacillus | PICC line | 245 | Vancomycin | 5.0 | 24 | 1 | 1 | Yes | No | No |